← Open Payments lookup

KATIE RUBIN: Open Payments

NPI 1013433978 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$410 in 22 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $266 · 2025 $410

Food & beverage: $410
CompanyPaymentsAmount
Astellas Pharma US Inc6$110
Amgen Inc.3$71
Lilly USA, LLC2$40
Sage Therapeutics, LLC2$37
MILLICENT US INC2$34
MAYNE PHARMA COMMERCIAL LLC2$26
Novo Nordisk Inc1$23
Bayer Healthcare Pharmaceuticals Inc.1$20
Supernus Pharmaceuticals, Inc.1$18
ABBVIE INC.1$16

Products named: Veozah, EVENITY, ZEPBOUND, ZURZUVAE, INTRAROSA, Wegovy, Mirena, Qelbree.

Industry payments across DE — which companies pay providers there.